Formal talks on the FTA would start in Brussels in April and India and EU have both expressed an explicit desire to sign the FTA by 2010. As informal talks have started between India and Europe on the free trade agreement (FTA) in New Delhi since Monday, apprehensions over provisions that could impact early access to generic medicines are being voiced in Thailand.

India is a major supplier of key HIV/AIDS drugs such as efavirenz, and heat stable lopinavir/ritonavir to the National Health Security scheme of the Thai government, which ensures free access to treatment for all Thais.

Concerns expressed by Thais range from patent term extensions, data exclusivity, criminalisation of patents enforcement (see bullet points), said to be a part of the FTA, is heavily shrouded in secrecy, with the texts and content of the deal guarded from any parliamentary debate or discussion.

Kannikar Kijtiwatchakul, coordinator, health consumer protection programme, Chulalongkom University in Thailand said that India is the pharmacy of the developing world, particularly Thailand.

According to Amit Sengupta, general secretary, All India Peoples Science Network, “India agreed to grant patents to medicines by signing Trips. Now with this FTA, EU is trying to force India to adopt higher standards of intellectual property. India has a moral and legal right to say no.”

Formal talks on the FTA would start in Brussels in April and India and EU have both expressed an explicit desire to sign the FTA by 2010.

India is a major supplier of key HIV/AIDS drugs such as efavirenz, and heat stable lopinavir/ritonavir to the National Health Security scheme of the Thai government, which ensures free access to treatment for all Thais.

Concerns expressed by Thais range from patent term extensions, data exclusivity, criminalisation of patents enforcement (see bullet points), said to be a part of the FTA, is heavily shrouded in secrecy, with the texts and content of the deal guarded from any parliamentary debate or discussion.

Kannikar Kijtiwatchakul, coordinator, health consumer protection programme, Chulalongkom University in Thailand said that India is the pharmacy of the developing world, particularly Thailand.

Formal talks on the FTA would start in Brussels in April and India and EU have both expressed an explicit desire to sign the FTA by 2010.

India is a major supplier of key HIV/AIDS drugs such as efavirenz, and heat stable lopinavir/ritonavir to the National Health Security scheme of the Thai government, which ensures free access to treatment for all Thais.

Concerns expressed by Thais range from patent term extensions, data exclusivity, criminalisation of patents enforcement (see bullet points), said to be a part of the FTA, is heavily shrouded in secrecy, with the texts and content of the deal guarded from any parliamentary debate or discussion.

Kannikar Kijtiwatchakul, coordinator, health consumer protection programme, Chulalongkom University in Thailand said that India is the pharmacy of the developing world, particularly Thailand.

From : DNA

About the author

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Sign Up for Our Newsletter

Get notified of our weekly selection of news

You May Also Like

Vietnam-India Strengthen Partnership and Trade

Vietnam and India are celebrating 50 years of close ties in 2022 and Birla’s visit is the latest after Vietnam’s National Assembly (NA) Chairman Vuong Dinh Hue visited India in December 2021. Vietnam and India established diplomatic relations in 1972.

What is the Indo-Pacific Economic Framework?

This article answers key questions around the US-led Indo-Pacific Economic Framework (IPEF), implications for member countries, and whether it will be able to counter China’s economic dominance in the Indo-Pacific region.

TAT signs LOI with THAI Airways to grow Indian tourist numbers to Thailand

To promote Thailand as a wedding and honeymoon destination for the Indian market, TAT is organising an Amazing Thailand Wedding EXPO 2022 this month to boost travellers from the segment.